| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.70B | +21.7% |
| Cost of Revenue | $2.36B | +13.5% |
| Gross Profit | $341.1M | +142.0% |
| R&D Expense | $66.2M | -0.2% |
| SG&A Expense | $173.0M | +26.9% |
| Interest Expense | $4.1M | +70.8% |
| Pre-tax Income | $39.6M | +139.5% |
| Income Tax | $9.2M | +102.4% |
| Net Income | $22.7M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $448.7M | +29.7% |
| Short-term Investments | $0 | — |
| Accounts Receivable | $216.5M | +109.3% |
| Inventory | $182.6M | -18.8% |
| Current Assets | $1.68B | +40.6% |
| Total Assets | $1.90B | +40.7% |
| Current Liabilities | $1.26B | +68.8% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $79.7M | +171.2% |
| Capital Expenditures | $8.1M | +171.5% |
| Investing Cash Flow | -$19.0M | -120.1% |
| Financing Cash Flow | -$8.7M | -116.5% |
| Free Cash Flow | $71.6M | +162.3% |
| +132.6% |
| EPS (Basic) | $0.18 | +130.0% |
| EPS (Diluted) | $0.13 | +121.7% |
| Long-term Debt |
| $0 |
| -100.0% |
| Total Liabilities | $1.30B | +62.7% |
| Stockholders' Equity | $472.1M | +17.3% |